Femara Aaster Health and Sports Solutions

£83.00

Letrozole (Femara) 2.5mg tablets are a third-generation aromatase inhibitor from Aaster Health and Sports Solutions, studied for estrogen biosynthesis suppression in laboratory research applications.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Femara Aaster Health and Sports Solutions
Femara Aaster Health and Sports Solutions
£83.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Letrozole Research Overview

Letrozole is a third-generation non-steroidal aromatase inhibitor extensively studied for its potent suppression of estrogen biosynthesis. This pharmaceutical-grade compound from Aaster Health and Sports Solutions represents one of the most effective aromatase inhibitors available for laboratory research applications. Our Stroid UK Shop provides this compound to support investigations into endocrine modulation and estrogen-dependent cellular processes.

The mechanism involves competitive inhibition of the aromatase enzyme (CYP19A1), which catalyses the final step in estrogen biosynthesis from androstenedione and testosterone. Letrozole demonstrates approximately 98% suppression of plasma estradiol levels in clinical studies, making it significantly more potent than first-generation inhibitors like aminoglutethimide.

Laboratory Research Applications

Researchers investigating estrogen-dependent pathways frequently examine letrozole for its ability to create controlled low-estrogen environments in experimental models. Studies have evaluated its effects on bone metabolism, cardiovascular function, and reproductive endocrinology. The compound’s selectivity for aromatase over other cytochrome P450 enzymes makes it valuable for specific enzymatic inhibition research.

Comparative studies with other aromatase inhibitors demonstrate letrozole’s superior potency and longer half-life characteristics. Research applications often involve investigating estrogen receptor modulation alongside selective androgen receptor modulators to understand hormonal interactions in tissue-specific contexts.

Compound Specifications

Letrozole Technical Data
Parameter Specification
CAS Number 112809-51-5
Molecular Formula C₁₇H₁₁N₅
Molecular Weight 285.31 g/mol
Purity ≥98% (verify with supplier)
Form Oral tablets
Storage Room temperature, dry conditions

Quality assurance protocols ensure consistent pharmaceutical-grade standards. Each batch undergoes analytical testing to verify identity and purity specifications. Storage recommendations maintain compound stability throughout the research period. Peptide research often incorporates aromatase inhibition studies to examine hormonal influences on protein synthesis pathways.

Research Compliance

This product is supplied exclusively for in-vitro laboratory research purposes. Not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with applicable regulations governing research chemical handling and disposal.

Related